Abstract
Knockout, Transgenic, Neurodegeneration, Maintenance of homeostasis, Lipid rafts
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
References for Section 4.1
Furukawa K et al (2017) Glycolipids: essential regulator of neuro-inflammation, metabolism and gliomagenesis. Biochim Biophys Acta 1861:2479–2484
Ji S et al (2016) Increased a-series gangliosides positively regulate leptin/Ob receptor-mediated signals in hypothalamus of GD3 synthase-deficient mice. Biochem Biophys Res Commun 479:453–460
Furukawa K et al (2016) Roles of glycosphingolipids in the regulation of the membrane organization and cell signaling in lipid rafts. In: Lipid/rafts. Nova Science Publishers, London, pp 129–146
Furukawa K et al (2014) Glycosphingolipids in the regulation of the nervous system. Adv Neurobiol 9:307–320
Ohmi Y et al (2014) Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord. J Neuroinflammation 11:61
References for Section 4.2
Lowe JB, Marth JD (2003) A genetic approach to mammalian glycan function. Annu Rev Biochem 72:643–691
Furukawa K et al (2007) Knockout mice and glycolipids. In: Kamerling JP et al (eds) Comprehensive glycoscience from chemistry to systems biology, vol 4. Elsevier, Oxford, pp 149–157
Honke K, Taniguchi N (2009) Animal models to delineate glycan functionality. In: Gabius H-J (ed) The sugar code, fundamentals of glycosciences. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, pp 385–401
Inokuchi J (2011) Physiopathological function of hematoside (GM3 ganglioside). Proc Jpn Acad Ser B Phys Biol Sci 87:179–198
Furukawa K et al (2017) Glycolipids: essential regulator of neuro-inflammation, metabolism and gliomagenesis. Biochim Biophys Acta 1861:2479–2484
References for Section 4.3
Laura M, Proia RL (2014) Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function. Glycoconj J 31:613–622
Simpson MA et al (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36:1225–1229
Boukhris A et al (2013) Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am J Hum Genet 93:118–123
Yoshikawa M et al (2015) Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells. Hum Mol Genet 24:2796–2807
Nagafuku M et al (2015) Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3. Glycobiology 25:303–318
References for Section 4.4
Haltiwanger RS, Lowe JB (2004) Role of glycosylation in development. Annu Rev Biochem 73:491–537
Apweiler R et al (1999) On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1473:4–8
Hang Q et al (2016) N-Glycosylation of integrin α5 acts as a switch for EGFR-mediated complex formation of integrin α5β1 to α6β4. Sci Rep 6:33507
Jaeken J, Peanne R (2017) What is new in CDG? J Inherit Metab Dis 40:569–586
References for Section 4.5
Mizumoto S et al (2014) Human genetic disorders and knockout mice deficient in glycosaminoglycan. Biomed Res Int 2014:495764
Kitakaze K et al (2016) Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model. J Clin Invest 126:1691–1703
Ito Z et al (2010) N-acetylglucosamine 6-O-sulfotransferase-1-deficient mice show better functional recovery after spinal cord injury. J Neurosci 30:5937–5947
Coles CH et al (2011) Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension. Science 332:484–488
Miyata S et al (2012) Persistent cortical plasticity by upregulation of chondroitin 6-sulfation. Nat Neurosci 15:414–422
References for Section 4.6
Mizumoto S et al (2013) Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans. J Biol Chem 288:10953–10961
Inatani M et al (2003) Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science 302:1044–1046
Forsberg E, Kjellen L (2001) Heparan sulfate: lessons from knockout mice. J Clin Invest 108:175–180
Irie F et al (2012) Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate. Proc Natl Acad Sci U S A 109:5052–5056
Jones KB et al (2009) A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci U S A 107:2054–2059
References for Section 4.7
Itoh K et al (2016) Mucin-type core 1 glycans regulate the localization of neuromuscular junctions and establishment of muscle cell architecture in Drosophila. Dev Biol 412: 114–127
Yamamoto-Hino M et al (2015) Phenotype-based clustering of glycosylation-related genes by RNAi-mediated gene silencing. Genes Cells 20: 521–542
Nishihara S (2010) Glycosyltransferases and transporters that contribute to proteoglycan synthesis in Drosophila: identification and functional analyses using the heritable and inducible RNAi system. Methods Enzymol 480: 323–51
Yamamoto-Hino M et al (2010) Identification of genes required for neural-specific glycosylation using functional genomics. PLoS Genet 23: e1001254
Ueyama M et al (2010) Increased apoptosis of myoblasts in Drosophila model for the Walker-Warburg syndrome. PLoS One 5: e11557
References for Section 4.8
McGary KL et al (2010) Systematic discovery of nonobvious human disease models through orthologous phenotypes. Proc Natl Acad Sci U S A 107:6544–6549
McWhite CD et al (2015) Applications of comparative evolution to human disease genetics. Curr Opin Genet Dev 35:16–24
Akiyoshi S et al (2015) RNAi screening of human glycogene orthologs in the nematode Caenorhabditis elegans and the construction of the C. elegans glycogene database. Glycobiology 25:8–20
Mizuguchi S et al (2003) Chondroitin proteoglycans are involved in cell division of Caenorhabditis elegans. Nature 423:443–448
Dejima K et al (2018) An aneuploidy-free and structurally defined balancer chromosome toolkit for Caenorhabditis elegans. Cell Rep 22:232–241
References for Section 4.9
NBRP Zebrafish: http://shigen.nig.ac.jp/zebra/
NBRP Medaka: https://shigen.nig.ac.jp/medaka/
Laughlin ST et al (2008) In vivo imaging of membrane-associated glycans in developing zebrafish. Science 320:664–667
Service RF (2012) Looking for a sugar rush. Science 338:321–323
References for Section 4.10
Liu J et al (2017) CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling. Hum Genet 136:1–12
Avsar-Ban E et al (2010) Protein O-mannosylation is necessary for normal embryonic development in zebrafish. Glycobiology 20:1089–1102
Uemura N et al (2015) Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein. PLoS Genet 11:e1005065
Keatinge M et al (2015) Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death. Hum Mol Genet 24:6640–6652
Newman M et al (2014) Using the zebrafish model for Alzheimer’s disease research. Front Genet 5:Article 189
References for Section 4.11
Westerfield M (2007) The Zebrafish book, 5th Edition; a guide for the laboratory use of zebrafish (Danio rerio), Eugene, University of Oregon Press. Distributed by the Institute of Neuroscience, University of Oregon, Copyright 1993 by Monte Westerfield, Edition 3; For on-line Edition 4, http://zfin.org/zf_info/zfbook/zfbk.html
Kinoshita M et al (2009) Medaka: biology, management, and experimental protocols. Willey-Blackwell, Ames
Tonoyama Y et al (2009) Essential role of β-1,4-galactosyltransferase 2 during medaka (Oryzias latipes) gastrulation. Mech Dev 126:580–594
Avsar-Ban E et al (2010) Protein O-mannosylation is necessary for normal embryonic development in zebrafish. Glycobiology 20:1089–1102
Moore CJ et al (2008) Genes required for functional glycosylation of dystroglycan are conserved in zebrafish. Genomics 92:159–167
References for Section 4.12
Westerfield M (2007) The Zebrafish book, 5th Edition; A guide for the laboratory use of zebrafish (Danio rerio). University of Oregon Press, Eugene
Hisano Y et al (2015) Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish. Sci Rep 5:8841
Hwang WY et al (2013) Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31:227–229
Ansai S, Kinoshita M (2017) Genome Editing of Medaka. Methods Mol Biol 1630:175–188
Hanzawa K et al (2017) Structures and developmental alterations of N-glycans of zebrafish embryos. Glycobiology 27:228–245
References for Section 4.13
Buchanan BB et al (2000) Biochemistry & molecular biology of plants. American Society of Plant Physiologists, Rockville
Lombard V et al (2014) The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res 42:D490–D495
Tan HT et al (2016) Emerging technologies for the production of renewable liquid transport fuels from biomass sources enriched in plant cell walls. Front Plant Sci 7:1854
Albersheim P et al (2011) Plant cell walls, Garland Science
Dicker M, Strasser R (2015) Using glyco-engineering to produce therapeutic proteins. Expert Opin Biol Ther 15:1501–1516
References for Section 4.14
Pedersen CT et al (2017) N-glycan maturation mutants in Lotus japonicus for basic and applied glycoprotein research. Plant J 91:394–497
Mercx S et al (2017) Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in Nicotiana tabacum BY-2 cells by a multiplex CRISPR/Cas9 strategy results in glycoproteins without plant-specific glycans. Front Plant Sci 8:403
Limkul J et al (2016) The production of human glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants. Plant Biotechnol J 14:1682–1694
von Schaewen A et al (2015) Arabidopsis thaliana KORRIGAN1 protein: N-glycan modification, localization, and function in cellulose biosynthesis and osmotic stress responses. Plant Signal Behav 10:e1024397
References for Section 4.15
Chiba Y et al (1998) Production of human compatible high mannose-type (Man5GlcNAc2) sugar chains in Saccharomyces cerevisiae. J Biol Chem 273:26298–26304
Choi BK et al (2003) Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc Natl Acad Sci U S A 100:5022–5027
Kuroda K et al (2008) Efficient antibody production upon suppression of O mannosylation in the yeast Ogataea minuta. Appl Environ Microbiol 74:446–453
Nett JH et al (2005) Cloning and disruption of the Pichia pastoris ARG1, ARG2, ARG3, HIS1, HIS2, HIS5, HIS6 genes and their use as auxotrophic markers. Yeast 22:295–304
Jacobs PP et al (2009) Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology. Nat Protoc 4:58–70
References for Section 4.16
Osada H (2010) Introduction of new tools for chemical biology research on microbial metabolites. Biosci Biotechnol Biochem 74:1135–1140
Miyazaki I et al (2010) A small-molecule inhibitor shows that pirin regulates migration of melanoma cells. Nat Chem Biol 6:667–673
Kato N et al (2012) Construction of a microbial natural product library for chemical biology studies. Curr Opin Chem Biol 16:101–108
Kawatani M et al (2015) Identification of matrix metalloproteinase inhibitors by chemical arrays. Biosci Biotechnol Biochem 79:1597–1602
Piotrowski JS et al (2017) Functional annotation of chemical libraries across diverse biologocal processes. Nat Chem Biol 13:982–993. (errata, 13, 1286)
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Furukawa, K. et al. (2019). Technologies to Elucidate Functions of Glycans. In: Taniguchi, N., et al. Glycoscience: Basic Science to Applications. Springer, Singapore. https://doi.org/10.1007/978-981-13-5856-2_4
Download citation
DOI: https://doi.org/10.1007/978-981-13-5856-2_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-5855-5
Online ISBN: 978-981-13-5856-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)